{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:09:07Z","timestamp":1790024947120,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.tube.2004.09.015","type":"journal-article","created":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T05:35:23Z","timestamp":1106717723000},"page":"47-52","source":"Crossref","is-referenced-by-count":107,"title":["Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials"],"prefix":"10.1016","volume":"85","author":[{"given":"Helen","family":"McShane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansar A.","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare R.","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilu P.","family":"Goonetilleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2004.09.015_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(91)90017-M","article-title":"The global tuberculosis situation and the new control strategy of the World Health Organization","volume":"72","author":"Kochi","year":"1991","journal-title":"Tubercle"},{"key":"10.1016\/j.tube.2004.09.015_bib2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.tube.2004.09.015_bib3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.tube.2004.09.015_bib4","first-page":"542","article-title":"Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya","volume":"61","author":"Orege","year":"1993","journal-title":"Int J Leprosy Mycobact Dis"},{"key":"10.1016\/j.tube.2004.09.015_bib5","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.4049\/jimmunol.162.9.5407","article-title":"Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis","volume":"162","author":"Caruso","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2004.09.015_bib6","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4","article-title":"Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells","volume":"30","author":"van Pinxteren","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2004.09.015_bib7","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1073\/pnas.93.6.2272","article-title":"Gamma\/delta and other unconventional T lymphocytes","volume":"93","author":"Kaufmann","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2004.09.015_bib8","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/35009119","article-title":"CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection","volume":"404","author":"Moody","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tube.2004.09.015_bib9","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2004.09.015_bib10","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2004.09.015_bib11","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199612263352602","article-title":"A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection","volume":"335","author":"Newport","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2004.09.015_bib12","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2004.09.015_bib13","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2004.09.015_bib14","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1002\/eji.200324109","article-title":"CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages","volume":"33","author":"Brookes","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2004.09.015_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"Schneider","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2004.09.015_bib16","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1128\/JVI.73.9.7524-7532.1999","article-title":"Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime\u2013modified vaccinia virus Ankara boost vaccination regimen","volume":"73","author":"Hanke","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.tube.2004.09.015_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime\u2013boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.tube.2004.09.015_bib18","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/IAI.70.3.1623-1626.2002","article-title":"Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A","volume":"70","author":"McShane","year":"2002","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.tube.2004.09.015_bib19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2004.09.015_bib20","unstructured":"Hill AVS. Unpublished data, 2003."},{"key":"10.1016\/j.tube.2004.09.015_bib21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins","volume":"79","author":"Blanchard","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.tube.2004.09.015_bib22","first-page":"375","article-title":"[The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)]","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol [B]"},{"key":"10.1016\/j.tube.2004.09.015_bib23","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","article-title":"Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques","volume":"19","author":"Stittelaar","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2004.09.015_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0264-410X(03)00538-3","article-title":"Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals","volume":"22","author":"Cosma","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2004.09.015_bib25","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1126\/science.276.5317.1420","article-title":"Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis","volume":"276","author":"Belisle","year":"1997","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.tube.2004.09.015_bib26","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of Bacille Calmette\u2013Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2004.09.015_bib27","doi-asserted-by":"crossref","unstructured":"Williams A, Hatch GJ, Clark SO, Gooch KE, Hatch KA, Hall GA, et al. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis Tuberculosis, this issue. doi:10.1016\/j.tube.2004.09.009.","DOI":"10.1016\/j.tube.2004.09.009"},{"key":"10.1016\/j.tube.2004.09.015_bib28","unstructured":"Goonetilleke, N., Gilbert, S.C., Hall, GA, Thornton, P.D., Wolfensohn, S.E., Huygen, K., McShane, H., Brookes, R.H., Hill, A.V.S. Vaccination of non-human primates against Mycobacterium tuberculosis with BCG and recombinant viral vectors expressing antigen 85A. 2004. Manuscript submitted for publication."},{"key":"10.1016\/j.tube.2004.09.015_bib29","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant Modified Vaccinia Virus Ankara Expressing Antigen 85A Boosts BCG-Primed And Naturally Acquired Anti-Mycobacterial Immunity In Humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/j.tube.2004.09.015_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(98)10448-8","article-title":"Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis","volume":"354","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tube.2004.09.015_bib31","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/IAI.71.4.2192-2198.2003","article-title":"Pulmonary necrosis resulting from DNA vaccination against tuberculosis","volume":"71","author":"Taylor","year":"2003","journal-title":"Infect Immun"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979204000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979204000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T19:53:16Z","timestamp":1682970796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979204000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1472979204000885"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2004.09.015","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}